Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/00/009
Active ingredient: Thalidomide
Indication: Treatment of erythema nodosum leprosum (ENL) or type II lepra reactions
Sponsor: Pharmion France
6/8 boulevard Haussmann, F-75009 Paris, France

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/01/2001 Centralised Orphan - Designation EMEA/OD/017/00 (2000)4256 of 29/12/2000
06/11/2002 Centralised Orphan - Transfer of orphan designation EMEA/OD/017/00/T/01 (2002)4307 of 05/11/2002
22/02/2007 Other procedure
06/11/2007 Other procedure
04/09/2008 Centralised Orphan - Removal of orphan designation from Community Register